Display options
Share it on

Front Mol Neurosci. 2017 Aug 07;10:247. doi: 10.3389/fnmol.2017.00247. eCollection 2017.

MPTP-Induced Dopamine Depletion in Basolateral Amygdala .

Frontiers in molecular neuroscience

Tingting Zhang, Tingting Chen, Peipei Chen, Baofeng Zhang, Juan Hong, Ling Chen

Affiliations

  1. State Key Lab of Reproductive Medicine, Nanjing Medical UniversityNanjing, China.
  2. Department of Physiology, Nanjing Medical UniversityNanjing, China.

PMID: 28824377 PMCID: PMC5545577 DOI: 10.3389/fnmol.2017.00247

Abstract

Anxiety disorders commonly occur in Parkinson's disease. Using field potential recording and patch-clamp recording, we evaluated influence of MPTP-reduced dopaminergic afferent in basolateral amygdala (BLA), a main region for affective regulation, on excitatory-inhibitory circuits and synaptic plasticity. Field excitatory post-synaptic potential (fEPSP) slopes at external capsule-BLA synapses were increased in MPTP-mice with decreases in paired-pulse facilitation and long-term potentiation amplitude, which were corrected by bath-application of D2R agonist quinpirole or cannabinoid type 1 receptors agonist WIN55,212-2, but not D1R agonist SKF38393. Compared to single waveform fEPSP in control mice, a multi-spike waveform fEPSP was observed in MPTP-mice with prolongation of duration and an increase in paired-pulse inhibition, which were recovered by BLA-injection of quinpirole for 2 days rather than bath-application. Density of GABA-evoked current (

Keywords: GABAA receptor (GABAAR); anxiety-like behaviors; basolateral amygdala (BLA); dopaminergic receptor (DR); synaptic plasticity

References

  1. Nature. 2002 May 16;417(6886):282-7 - PubMed
  2. Neurodegener Dis. 2005;2(1):44-8 - PubMed
  3. Front Mol Neurosci. 2014 Jul 03;7:62 - PubMed
  4. Lancet Neurol. 2009 Dec;8(12):1128-39 - PubMed
  5. Neuropsychopharmacology. 2004 Oct;29(10):1852-64 - PubMed
  6. Brain Struct Funct. 2008 Sep;213(1-2):159-75 - PubMed
  7. J Neurosci. 2009 Sep 9;29(36):11089-97 - PubMed
  8. J Neurosci. 2013 Aug 28;33(35):14075-86 - PubMed
  9. Neuropharmacology. 2017 Apr;116:387-398 - PubMed
  10. Brain Struct Funct. 2017 May;222(4):1767-1784 - PubMed
  11. J Neurochem. 2010 Aug;114(3):750-60 - PubMed
  12. Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15130-5 - PubMed
  13. Synapse. 1997 Feb;25(2):185-95 - PubMed
  14. J Comp Neurol. 2004 May 17;473(1):137-46 - PubMed
  15. J Neurophysiol. 2007 Nov;98(5):2956-61 - PubMed
  16. Neuron. 2009 Jun 25;62(6):757-71 - PubMed
  17. Brain Res. 2009 Apr 24;1267:65-76 - PubMed
  18. Synapse. 2002 Aug;45(2):86-94 - PubMed
  19. Brain Struct Funct. 2017 Aug;222(6):2473-2485 - PubMed
  20. Neurodegener Dis. 2011;8(4):230-9 - PubMed
  21. Neurosci Lett. 2000 Sep 15;291(2):69-72 - PubMed
  22. Neuropharmacology. 2016 Jun;105:124-32 - PubMed
  23. Neuroscience. 2001;107(1):85-97 - PubMed
  24. J Neurochem. 2011 Feb;116(4):554-63 - PubMed
  25. J Neurophysiol. 2001 Aug;86(2):717-23 - PubMed
  26. Cell Tissue Res. 2004 Oct;318(1):215-24 - PubMed
  27. J Neurosci. 2006 Feb 1;26(5):1465-9 - PubMed
  28. J Neurosci. 2008 Dec 24;28(52):14018-30 - PubMed
  29. Brain Struct Funct. 2009 Feb;213(3):275-88 - PubMed
  30. J Neurosci. 2005 Sep 21;25(38):8725-34 - PubMed
  31. J Neurosci. 2009 Dec 16;29(50):15713-20 - PubMed
  32. Front Mol Neurosci. 2016 Oct 13;9:101 - PubMed
  33. Pharmacol Biochem Behav. 2014 Sep;124:5-12 - PubMed
  34. Int J Dev Neurosci. 2015 Dec;47(Pt B):320-32 - PubMed
  35. Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12107-12 - PubMed
  36. Prog Neurobiol. 2010 Feb 9;90(2):198-216 - PubMed
  37. Neuropsychopharmacology. 2011 Apr;36(5):1090-103 - PubMed
  38. Proc Natl Acad Sci U S A. 2006 May 23;103(21):8251-6 - PubMed
  39. Front Mol Neurosci. 2016 Aug 26;9:77 - PubMed
  40. Adv Pharmacol. 2015;72:97-146 - PubMed
  41. J Neurosci. 2016 Jan 27;36(4):1242-53 - PubMed
  42. Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11383-8 - PubMed
  43. Mol Cell Neurosci. 2004 Apr;25(4):732-41 - PubMed
  44. J Neurosci. 2004 Nov 24;24(47):10652-9 - PubMed
  45. Eur J Neurosci. 2004 Sep;20(5):1281-9 - PubMed
  46. Neuroscience. 2016 Jan 15;312:1-9 - PubMed
  47. Hippocampus. 2002;12(5):592-9 - PubMed
  48. J Biol Chem. 2010 Dec 31;285(53):41795-805 - PubMed
  49. Eur J Neurosci. 2014 Dec;40(11):3635-52 - PubMed
  50. Nat Neurosci. 2003 Jun;6(6):587-92 - PubMed
  51. J Neurosci. 2010 Feb 17;30(7):2433-41 - PubMed
  52. J Neurosci Res. 2016 Jun;94(6):548-67 - PubMed
  53. Front Synaptic Neurosci. 2010 Jun 23;2:22 - PubMed
  54. Brain Res. 2014 Jun 3;1567:57-65 - PubMed
  55. J Neurosci. 2003 May 15;23(10):4081-91 - PubMed
  56. Neuron. 2014 Jan 22;81(2):428-37 - PubMed
  57. Postgrad Med J. 2001 Feb;77(904):89-93 - PubMed
  58. Neuropharmacology. 2012 Feb;62(2):797-806 - PubMed
  59. Biomol Ther (Seoul). 2016 Mar 1;24(2):115-22 - PubMed
  60. Neurobiol Aging. 2003 Mar-Apr;24(2):197-211 - PubMed
  61. Neuroscience. 1999;92 (4):1261-72 - PubMed
  62. J Neurophysiol. 2005 Mar;93(3):1598-610 - PubMed
  63. Brain Res. 1995 May 22;680(1-2):43-52 - PubMed
  64. Pharmacol Biochem Behav. 2012 Dec;103(2):181-6 - PubMed

Publication Types